147 related articles for article (PubMed ID: 35431174)
1. Oral squamous cell carcinoma in the young patient: an emerging unique cohort of patients.
Kolokythas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):617. PubMed ID: 35431174
[No Abstract] [Full Text] [Related]
2. RE: Association Between the Extent of Extranodal Extension and Survival Outcome in Oral Cavity Squamous Cell Carcinoma.
Mamic M; Luksic I
J Oral Maxillofac Surg; 2023 May; 81(5):522-523. PubMed ID: 37137656
[No Abstract] [Full Text] [Related]
3. Early Discovery, Early Recovery: The principle behind successful oral squamous cell carcinoma treatment!
Misra SR; Das R
Oral Oncol; 2023 Oct; 145():106511. PubMed ID: 37478573
[No Abstract] [Full Text] [Related]
4. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
5. Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
Jayaseelan VP; A S SG; Arumugam P
Oral Oncol; 2022 Jul; 130():105874. PubMed ID: 35533508
[No Abstract] [Full Text] [Related]
6. Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
Yang X; Zhou T; Ji T; Jia H; Liu W
Oral Oncol; 2022 Jul; 130():105901. PubMed ID: 35533509
[No Abstract] [Full Text] [Related]
7. 'T4b' or not to 'T4b': addressing the resectability in T4b oral cavity squamous cell carcinoma.
Joy A; Subash A; Thakur S; Rao V
Int J Oral Maxillofac Surg; 2022 Dec; 51(12):1605-1606. PubMed ID: 35599081
[No Abstract] [Full Text] [Related]
8. Do demographics and tumour-related factors affect nodal yield at neck dissection? A retrospective cohort study.
Lim RS; Evans L; George AP; de Alwis N; Stimpson P; Merriel S; Giddings CE; Billah B; Smith JA; Safdar A; Sigston E
J Laryngol Otol; 2017 Jan; 131(S1):S36-S40. PubMed ID: 27786150
[TBL] [Abstract][Full Text] [Related]
9. [Survival of young adults with oral squamous cell carcinoma in a brazilian population].
Amorim MM; Leite MCS; Alves LDB; Silva CALD; Santos JND; Freitas VS
Rev Salud Publica (Bogota); 2019 Sep; 21(5):534-540. PubMed ID: 36753205
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of CD8-to-EGFR ratio in salivary microvesicles of patients with oral squamous cell carcinoma.
Man QW; Li RF; Zhong NN; Liu B
Oral Dis; 2023 May; 29(4):1480-1486. PubMed ID: 35029008
[No Abstract] [Full Text] [Related]
11. Methuosis - A promising lead for the treatment of oral squamous cell carcinoma.
Krishnan RP; Ramani P; Pandiar D
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1S):101333. PubMed ID: 36402427
[No Abstract] [Full Text] [Related]
12. Outcomes of Oral and Oropharyngeal Squamous Cell Carcinoma Related to Healthcare Coverage: A Retrospective Cohort Study in Brazil.
Dantas TS; de Sousa ASA; Sales TOP; deOliveira Filho OV; de Barros Silva PG; Alves APNN; Mota MRL; Sousa FB
Cancer Invest; 2022 Sep; 40(8):680-692. PubMed ID: 35731734
[TBL] [Abstract][Full Text] [Related]
13. [Squamous cell carcinoma as the most common oral carcinoma. Diagnosis and therapy].
Balakirski G; Hölzle F; Megahed M
Hautarzt; 2014 May; 65(5):390-2. PubMed ID: 24820795
[TBL] [Abstract][Full Text] [Related]
14. Level IIB dissection in early stages cT1-T2 oral squamous cell carcinomas: pros and cons.
Frandjian H; van Maanen A; Mahy P; Guyot L; Graillon N; Magremanne M
J Stomatol Oral Maxillofac Surg; 2022 Jun; 123(3):377-382. PubMed ID: 34273573
[No Abstract] [Full Text] [Related]
15. Elective neck dissection may not necessarily reduce recurrence and improve survival in all cases of early stage (CT1/2 N0 M0) oral squamous cell carcinoma.
Chuang SK; Lee KC
J Evid Based Dent Pract; 2021 Jun; 21(2):101573. PubMed ID: 34391558
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase-2 expression in oral squamous cell carcinoma.
Campagna R; Pozzi V; Salvucci A; Togni L; Mascitti M; Sartini D; Salvolini E; Santarelli A; Lo Muzio L; Emanuelli M
Hum Cell; 2023 May; 36(3):1211-1213. PubMed ID: 36774414
[No Abstract] [Full Text] [Related]
17. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma - "Need for incorporation of sub classification of pT4b lesions".
Amith K P ; V Lal R; Lakshmi Pandey R; Thakur S
Oral Oncol; 2022 Sep; 132():106014. PubMed ID: 35835054
[No Abstract] [Full Text] [Related]
18. Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?
Ramdoss R; Yuwanati M; Viola E A; Ramani P; Murugan MS
Oral Oncol; 2022 Jan; 124():105672. PubMed ID: 34920376
[No Abstract] [Full Text] [Related]
19. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
20. Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma.
Vijayashree Priyadharsini J; Abilasha R; Anitha P; Paramasivam A
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1):101277. PubMed ID: 36058533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
